CDw150 associates with Src-homology 2-containing inositol phosphatase and modulates CD95-mediated apoptosis

Journal of Immunology

Volumn 162, Issue 10, 1999, Pages 5719-5727

  Mikhalap, Svitlana V ^a   Shlapatska, Larisa M ^a   Berdova, Anna G ^a   Law, Che Leung ^b,c   Clark, Edward A ^b   Sidorenko, Svetlana P ^a,b  

^a R E KAVETSKY INSTITUTE OF EXPERIMENTAL PATHOLOGY   (Ukraine)

^b UNIVERSITY OF WASHINGTON   (United States)

^c Xcyte Therapies Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; GLYCOPROTEIN; GLYCOPROTEIN CDW150; INOSITOL POLYPHOSPHATE; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE PHOSPHATASE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; B LYMPHOCYTE; DEPHOSPHORYLATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION;

ANTIGENS, CD; ANTIGENS, CD45; ANTIGENS, CD95; APOPTOSIS; B-LYMPHOCYTES; CARRIER PROTEINS; GLYCOPROTEINS; IMMUNOGLOBULINS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOPROLIFERATIVE DISORDERS; PHOSPHORIC MONOESTER HYDROLASES; PROTEIN BINDING; PROTEIN-SERINE-THREONINE KINASES; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR AGGREGATION; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION; SRC HOMOLOGY DOMAINS; SRC-FAMILY KINASES;

EID: 0033563218     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (68)

1. Goodnow, C. C. 1996. Balancing immunity and tolerance: deleting and tuning lymphocyte repertoires. Proc. Natl. Acad. Sci. USA 93:2264.
2. DeFranco, A. L. 1997. The complexity of signaling pathways activated by the BCR. Curr. Opin. Immunol. 9:296.
3. Liu, Y. J., and C. Arpin. 1997. Germinal center development. Immunol. Rev. 156:111.
4. Healy, J. I., and C. C. Goodnow. 1998. Positive versus negative signaling by lymphocyte antigen receptors. Annu. Rev. Immunol. 16:645.
5. Mason, D. Y., M. Jones, D. L. Hardie, G. van Schijndel, G. D. Johnson, R. van Lier, and J. C. M. McLennan. 1997. BC28: blind panel report. In Leucocyte Typing VI, T. Kishimoto, H. Kikutani, A. E. G. Kr. von dem Borne, S. M. Goyert, D. Y. Mason, M. Miyasaka, L. Moretta, K. Okumura, S. Shaw, T. A. Springer, K. Sugamura, and M. Zola, eds. Garland Publishing, New York, p. 206-229.
6. Sidorenko, S. P. 1997. CDw150 cluster report. In Leucocyte Typing VI. T. Kishimoto, H. Kikutani, A. E. G. Kr. von dem Borne, S. M. Goyert, D. Y. Mason, M. Miyasaka, L. Moretta, K. Okumura, S. Shaw, T. A. Springer, K. Sugamura, and M. Zola, eds. Garland Publishing, New York, p. 582-584.
7. Zola, H., S. Nobbs, and D. Bates. 1997. NL1: non-lineage antigens: section report. In Leucocyte Typing VI. T. Kishimoto, H. Kikutani, A. E. G. Kr. von dem Borne, S. M. Goyert, D. Y. Mason, M. Miyasaka, L. Moretta, K. Okumura, S. Shaw, T. A. Springer, K. Sugamura, and M. Zola, eds. Garland Publishing, New York, p. 469-477.
8. Sidorenko, S. P., and E. A. Clark. 1993. Characterization of a cell surface glycoprotein IPO-3, expressed on activated human B and T lymphocytes. J. Immunol. 151:4614.
9. Cocks, B. G., C. C. Chang, J. M. Carballido, H. Yssel, J. E. de Vries, and G. Aversa. 1995. A novel receptor involved in T-cell activation. Nature 376:260.
10. Polacino, P. S., L. M. Pinchuk, S. P. Sidorenko, and E. A. Clark. 1996. Immunodeficiency virus cDNA synthesis in resting T lymphocytes is regulated by T cell activation signals and dendritic cells. J. Med. Primatol. 25:201.
11. Pinchouk, V. G., S. P. Sidorenko, D. F. Gluzman, E. P. Vetrova, A. G. Berdova, and L. N. Schlapatskaya, 1988. Monoclonal antibodies IPO-3 and IPO-10 against human B cell differentiation antigens. Anticancer Res. 8: 1377.
12. Sidorenko, S. P., E. P. Vetrova, O. V. Yurchenko, A. G. Berdova, L. N. Shlapatskaya, and D. F. Gluzman. 1992. Monoclonal antibodies of IPO series against B cell differentiation antigens in leukemia and lymphoma immunophenotyping. Neoplasma 39:3.
13. Punnonen, J., B. G. Cocks, J. M. Carballido, B. Bennett, D. Peterson, G. Aversa, and J. E. de Vries. 1997. Soluble and membrane-bound forms of signaling lymphocytic activation molecule (SLAM) induce proliferation and Ig synthesis by activated human B lymphocytes. J. Exp. Med. 185:993.
14. Aversa, G., C. C. Chang, J. M. Carballido, B. G. Cocks, and J. E. de Vries. 1997. Engagement of the signaling lymphocytic activation molecule (SLAM) on activated T cells results in IL-2-independem, cyclosporin A-sensitive T cell proliferation and IFN-gamma production. J. Immunol. 158:4036.
15. Aversa, G., J. Carballido, J. Punnonen, C. C. Chang. T. Hauser, B. G. Cocks, and J. E. De Vries. 1997. SLAM and its role in T cell activation and Th cell responses. Immunol. Cell. Biol. 75:202.
16. Sayos, J., C. Wu, M. Morra, N. wang, X. Zhang, D. Allen, S. van Schaik, L. Nolarangelo, R. Geha, M. G. Roncarolo, H. Oettgen, J. E. De. Vries, and C. Terhorst. 1998. The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM. Nature 395:462.
17. Nichols, K. E., D. P. Harkin, S. Levitz, M. Krainer, K. A. Kolquist, C. Genovese, A. Bernard, M. Ferguson, L. Zuo, E. Snyder, A. J. Buckler, C. Wise, J. Ashley, M. Lovett, M. B. Valentine, A. T. Look, W. Gerald, D. E. Housman, and D. A. Habet. 1998. Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome. Proc. Natl. Acad. Sci. USA 95:13765.
18. Seemayer, T. A., T. G. Gross, R. M. Egeler, S. J. Pirruccello, J. R. Davis, C. M. Kelly, M. Okano, A. Lanyi, and J. Sumegi. 1995. X-linked lymphoproliferative disease: twenty-five years after the discovery. Pediatr. Res 38:471.
19. Klaus, S. J., S. P. Sidorenko, and E. A. Clark. 1996. CD45 ligation induces programmed cell death in T and B lymphocytes. J. Immunol. 156:2743.
20. Clark, E. A., and J. A. Ledbetter. 1986. Activation of human B cells mediated through two distinct cell surface differentiation antigens, Bp35 and Bp50. Proc. Natl. Acad. Sci. USA 83:4494.
21. Ledbetter, J. A., N. K. Tonks, E. H. Fischer, and E. A. Clark. 1988. CD45 regulates signal transduction and lymphocyte activation by specific association with receptor molecules on T or B cells. Proc. Natl. Acad. Sci. USA 85:8628.
22. Valentine, M. A., E. A. Clark, G. L. Shu, N. A. Norris, and J. A. Ledbetter. 1988. Antibody to a novel 95-kDa surface glycoprotein on human B cells induces calcium mobilization and B cell activation. J. Immunol. 140:4071.
23. Law, C. L., K. A. Chandran, S. P. Sidorenko, and E. A. Clark. 1996. Phospholipase C-γl interacts with conserved phosphotyrosyl residues in the linker region of Syk and is a substrate for Syk. Mol. Cell. Biol. 16:1305.
24. Law, C. L., S. P. Sidorenko, K. A. Chandran, Z. Zhao, S. H. Shen, E. H. Fischer, and E. A. Clark. 1996. CD22 associates with protein tyrosine phosphatase 1C, Syk, and phospholipase C-γl upon B cell activation. J. Exp. Med. 183:547.
25. Law, C. L., S. P. Sidorenko, K. A. Chandran, K. E. Draves, A. C. Chan, A. Weiss, S. Edelhoff, C. M. Disteche, and E. A. Clark. 1994. Molecular cloning of human Syk: a B cell protein-tyrosine kinase associated with the surface immunoglobulin M-B cell receptor complex. J. Biol. Chem. 269:12310.
26. Martin, S. J., C. P. Reutelingsperger, A. J. McGahon, J. A. Rader, R. C. van Schie, D. M. LaFace, and D. R. Green. 1995. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J. Exp. Med. 182:1545.
27. Leprince, C., K. E. Draves, J. A. Ledbetter, R. M. Torres, and E. A. Clark. 1992. Characterization of molecular components associated with surface immunoglobulin M in human B lymphocytes: presence of tyrosine and serine/threonine protein kinases. Eur. J. Immunol. 22:2093.
28. Sidorenko, S. P., C. L. Law, S. J. Klaus, K. A. Chandran, M. Takata, T. Kurosaki, and E. A. Clark. 1996. Protein kinase Cμ (PKCμ) associates with the B cell antigen receptor complex and regulates lymphocyte signaling. Immunity. 5:353.
29. Bolen, J. E. 1995. Protein tyrosine kinases in the initiation of antigen receptor signaling. Curr. Opin. Immunol. 7:306.
30. Law, C. L., A. Craxton, K. L. Otipoby, S. P. Sidorenko, S. J. Klaus, and E. C. Clark. 1996. Regulation of signalling through B-lymphocyte antigen receptors by cell-cell interaction molecules. Immunol. Rev. 153:123.
31. Crowley, M. T., S. L. Harmer, and A. L. DeFranco. 1996. Activation-induced association of a 145-kDa tyrosine-phosphorylated protein with Shc and Syk in B lymphocytes and macrophages. J. Boil. Chem. 271:1145.
32. Lamkin, T. D., S. F. Walk, L. Liu, J. E. Damen, G. Krystal, and K. S. Ravichandran. 1997. Shc interaction with Src homology 2 domain containing inositol phosphatase (SHIP) in vivo requires the Shc-phosphotyrosine binding domain and two specific phosphotyrosines on SHIP. J. Biol. Chem. 272:10396.
33. Liu, L., J. E. Damen, M. D. Ware, and G. Krystal. 1997. Interleukin-3 induces the association of the inositol 5-phosphatase SHIP with SHP2. J. Biol. Chem. 272: 10998.
34. Liu, L., J. E. Damen, M. R. Hughes, I. Babic, F. R. Jirik, and G. Krystal. 1997. The Src homology 2 (SH2) domain of SH2-containing inositol phosphatase (SHIP) is essential for tyrosine phosphorylation of SHIP, its association with Shc, and its induction of apoptosis. J. Biol. Chem. 272:8983.
35. Tridandapani, S., T. Kelley, M. Pradhan, D. Cooney, L. B. Justement, and K. M. Coggeshall. 1997. Recruitment and phosphorylation of SH2-containing inositol phosphatase and Shc to the B-cell fcy immunoreceptor tyrosine-based inhibition motif peptide motif. Mol. Cell. Biol. 17:4305.
36. Tridandapani, S., T. Kelley, D. Cooney, M. Pradhan, and K. M. Coggeshall. 1997. Negative signaling in B cells: SHIP Grbs Shc. Immunol. Today 18:424.
37. Kuroiwa, A., Y. Yamashita, M. Inui, T. Yuasa, M. Ono, A. Nagabukuro, Y. Matsuda, and T. Takai. 1998. Association of tyrosine phosphatases SHP-1 and SHP-2, inositol 5-phosphatase SHIP with gp49B1, and chromosomal assignment of the gene. J. Biol. Chem. 273:1070.
38. Sidorenko, S. P., G. Shu, K. E. Draves, L. M. Pinchuk, S. V. Mikhalap, Z. Zhao, and E. A. Clark. 1997. The IPO-3/SLAM surface molecule associates with protein kinase activities and CD45 in B lymphocytes. In Leucocyte Typing VI. T. Kishimoto, M. Kikutani, A. E. G. Kr. von dem Borne, S. M. Goyert, D. Y. Mason, M. Miyasaka, L. Moretta, K. Okumura, S. Shaw, T. A. Springer, K. Sugamura, and M. Zola, eds. Garland Publishing, New York, p. 584-585.
39. Hof, P., S. Pluskey, S. Dhe-Paganon, M. J. Eck, and S. E. Shoelson. 1998. Crystal structure of the tyrosine phosphatase SHP-2. Cell 92:441.
40. Katagiri, K., K. K. Yokoyama, T. Yamamoto, S. Omura, S. Irie, and T. Katagiri. 1996. Lyn and Fgr protein-tyrosine kinases prevent apoptosis during retinoic acid-induced granulocytic differentiation of HL-60 cells. J. Biol. Chem. 271: 11557.
41. Ono, M., H. Okada, S. Bolland, S. Yanagi, T. Kurosaki, and J. V. Ravetch. 1997. Deletion of SHIP or SHP-1 reveals two distinct pathways for inhibitory signaling. Cell 90:293.
42. Rathmell, J. C., S. E. Townsend, J. C. Xu, R. A. Flavell, and C. C. Goodnow. 1996. Expansion or elimination of B cells in vivo: dual roles for CD40-and Fas (CD95)-ligands modulated by the B cell antigen receptor. Cell 87:319.
43. Alessi, D. R., and P. Cohen. 1998. Mechanism of activation and function of protein kinase B. Curr. Opin. Genet Dev. 8:55.
44. Downward, J. 1998. Mechanisms and consequences of activation of protein kinase B/Akt. Curr. Opin. Cell. Biol. 10:262.
45. Marte, B. M., and J. Downward. 1997. PKB/Akt: connecting phosphoinositide 3-kinase to cell survival and beyond. Trends Biochem. Sci. 22:355.
46. Liu, L., J. E. Damen, R. L. Cutler, and G. Krystal. 1994. Multiple cytokines stimulate the binding of a common 145-kilodallon protein to Shc at the Grb2 recognition site of Shc. Mol. Cell. Biol. 14:6926.
47. Ruzzene, M., A. M. Brunati, A. Donella-Deana, O. Marin, and L. A. Pinna. 1997. Specific stimulation of c-Fgr kinase by tyrosine-phosphorylated (poly)peptides - possible implication in the sequential mode of protein phosphorylation. Eur. J. Biochem. 245:701.
48. Damen, J. E., L. Liu, P. Rosten, R. K. Humphries, A. B. Jefferson, P. W. Majerus, and G. Krystal. 1996. The 145-kDa protein induced to associate with Shc by multiple cytokines is an inositol tetraphosphate and phosphatidylinositol 3,4,5-triphosphate 5-phosphatase. Proc. Natl. Acad. Sci. USA 93:1689.
49. Lioubin, M. N., P. A. Algate, S. Tsai, K. Carlberg, A. Aebersold, and L. R. Rohrschneider. 1996. p150Ship, a signal transduction molecule with inositol polyphosphate-5-phosphatase activity. Genes Dev. 10:1084.
50. Coggeshall, K. M. 1998. Inhibitory signaling by B cell FcγRIIb. Curr. Opin. Immunol. 10:306.
51. Chacko, G. W., S. Tridandapani, J. E. Damen, L. Liu, G. Krystal, and K. M. Coggeshall. 1996. Negative signaling in B lymphocytes induces tyrosine phosphorylation of the 145-kDa inositol polyphosphate 5-phosphatase, SHIP. J. Immunol. 157:2234.
52. D'Ambrosio, D., D. C. Fong, and J. C. Cambier. 1996. The SHIP phosphatase becomes associated with FcγRIIB1 and is tyrosine phosphorylated during 'negative' signaling. Immunol. Lett. 54:77.
53. Ono, M., S. Bolland, P. Tempst, and J. V. Ravetch. 1996. Role of the inositol phosphatase SHIP in negative regulation of the immune system by the receptor FcγRIIB. Nature 383:263.
54. Osborne, M. A., G. Zenner, M. Lubinus, X. Zhang, Z. Songyang, L. C. Cantley, P. Majerus, P. Burn, and J. P. Kochan. 1996. The inositol 5′-phosphatase SHIP binds to immunoreceptor signaling motifs and responds to high affinity IgE receptor aggregation. J. Biol. Chem, 271:29271.
55. Pradhan, M., and K. M. Coggeshall. 1997. Activation-induced bi-dentate interaction of SHIP and Shc in B lymphocytes. J. Cell Biochem. 67:32.
56. Sarmay, G., G. Koncz, I. Pecht, and J. Gergely. 1997. Fcy receptor type IIb induced recruitment of inositol and protein phosphatases to the signal transductory complex of human B-cell. Immunol. Lett. 57:159.
57. Franke, T. F., D. R. Kaplan, and L. C. Cantley. 1997. PI3K: downstream AKTion blocks apoptosis. Cell 88:435.
58. Datta, S. R., H. Dudek, X. Tao, S. Masters, H. Fu, Y. Gotoh, and M. E. Greenberg. 1997. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91:231.
59. del Peso, L., M. Gonzalez-Garcia, C. Page, R. Herrera, and G. Nunez. 1997. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science 278:687.
60. Hashimoto, A., H. Okada, A. Jiang, M. Kurosaki, S. Greenberg, E. A. Clark, and T. Kurosaki. 1998. Involvement of GTPases and phospholipase C-γ2 in ERK, JNK and p38 MAP kinase activation by the B cell antigen receptor. J. Exp. Med. 188:1287.
61. Bolland, S., R. N. Pearse, T. Kurosaki, and J. V. Ravetch. 1998. SHIP modulates immune receptor responses by regulating membrane association of Btk. Immunity 8:509.
62. Scharenberg, A. M., O. El-Hillal, D. A. Fruman, L. O. Beitz, Z. Li, S. Lin, I. Gout, L. C. Cantley, D. J. Rawlings, and J. P. Kinet. 1998. Phosphatidylinositol-3,4,5-trisphosphate (PtdIns-3,4,5-P3)/Tec kinase-dependent calcium signaling pathway: a target for SHIP-mediated inhibitory signals. EMBO J. 17:1961.
63. 2+ following B-cell receptor activation. EMBO J. 17:1973.
64. Takata, M., and T. Kurosaki. 1996. A role for Bruton's tyrosine kinase in B cell antigen receptor-mediated activation of phospholipase C-γ2. J. Exp. Med. 184: 31.
65. Orrenius, S., D. J. McConkey, and P. Nicotera. 1991. Role of calcium in toxic and programmed cell death. Adv. Exp. Med Biol. 283:419.
66. Graves, J. D., K. E Draves, A. Craxton, J. Saklatvala, E. G. Krebs, and E. A. Clark. 1996. Involvement of stress-activated protein kinase and p38 mitogen-activated protein kinase in mlgM-induced apoptosis of human B lymphocytes. Proc. Natl. Acad. Sci. USA 93:13814.
67. Jiang, A., A. Craxton, T. Kurosaki, and E. A. Clark. 1998. Different protein tyrosine kinases are required for B cell antigen receptor-mediated ERK, JNK1 and p38 MAPK kinase activation. J. Exp. Med. 188:1297.
68. 2+ level. J. Immunol. 154:599.